Publicaciones (31) Publicaciones de ELIA DEL CERRO PEÑALVER

2024

  1. Hypofractionated whole breast IMRT with HDR brachytherapy boost in early-stage breast cancer: Long-term results from a single-center

    Brachytherapy

2023

  1. Jorge clinical study: 10-year outcomes of risk-adapted radiotherapy defined by multiparametric MRI for prostate cancer

    World Journal of Urology, Vol. 41, Núm. 12, pp. 3829-3838

2022

  1. IJRadiation therapy for recurrent hydatid cyst of the pelvic bone: a case report

    International Journal of Infectious Diseases, Vol. 115, pp. 168-170

2021

  1. Breast cancer radiotherapy: What physicians need to know in the era of the precision medicine

    Breast Disease, Vol. 40, Núm. 1, pp. 1-16

  2. Breast radiotherapy-related cardiotoxicity. When, how, why. risk prevention and control strategies

    Cancers, Vol. 13, Núm. 7

2020

  1. Breast radiotherapy in elderly women: Myths, controversies, and current techniques in the adjuvant setting

    Translational Cancer Research, Vol. 9, pp. S37-S55

  2. Clinical applications of molecular biomarkers in prostate cancer

    Cancers, Vol. 12, Núm. 6, pp. 1-25

  3. High-dose neoadjuvant chemoradiotherapy versus chemotherapy alone followed by surgery in potentially-resectable stage IIIA-N2 NSCLC. A multi-institutional retrospective study by the Oncologic Group for the Study of Lung Cancer (Spanish Radiation Oncology Society)

    Reports of Practical Oncology and Radiotherapy, Vol. 25, Núm. 3, pp. 447-455

  4. Impact of 68Ga-PSMA PET/CT in the treatment of prostate cancer: Initial experience in Spain

    Reports of Practical Oncology and Radiotherapy, Vol. 25, Núm. 3, pp. 405-411

  5. Patient safety in radiation oncology in Spain: a need to change

    Clinical and Translational Oncology, Vol. 22, Núm. 5, pp. 751-758

2019

  1. Management of oligometastatic non-small cell lung cancer patients: Current controversies and future directions

    WORLD JOURNAL OF CLINICAL ONCOLOGY, Vol. 10, Núm. 10, pp. 318-339

  2. Multiparametric magnetic resonance imaging-guided salvage radiotherapy in prostate cancer

    Reports of Practical Oncology and Radiotherapy, Vol. 24, Núm. 5, pp. 472-480

  3. Prognostic factors in neoadjuvant treatment followed by surgery in stage IIIA-N2 non-small cell lung cancer: a multi-institutional study by the Oncologic Group for the Study of Lung Cancer (Spanish Radiation Oncology Society)

    Clinical and Translational Oncology, Vol. 21, Núm. 6, pp. 735-744

2018

  1. Importance of 68Ga-PSMA PET/CT in hospital practice. View of the radiation oncologist

    Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 37, Núm. 5, pp. 302-314

  2. Infrastructure and equipment for radiation oncology in the Spanish National Health System: analysis of external beam radiotherapy 2015–2020

    Clinical and Translational Oncology, Vol. 20, Núm. 3, pp. 402-410

  3. Neoadjuvant treatment followed by surgery versus definitive chemoradiation in stage IIIA-N2 non-small-cell lung cancer: A multi-institutional study by the oncologic group for the study of lung cancer (Spanish Radiation Oncology Society)

    Lung Cancer, Vol. 118, pp. 119-127

  4. Response to: Low level evidence supporting the choice of optimal multimodality treatment approach in patients with stage IIIA NSCLC- ain't no mountain high enough…. to keep me getting to you by Jeremic Branislav

    Lung Cancer

2017

  1. Magnetic resonance imaging for prostate cancer before radical and salvage radiotherapy: What radiation oncologists need to know

    World Journal of Clinical Oncology, Vol. 8, Núm. 4, pp. 305-319

2016

  1. Carcinoma de cavum

    Revisiones en Cancer, Vol. 30, Núm. 4, pp. 182-194

  2. Endorectal magnetic resonance imaging for risk classification of localized prostate cancer: Radiographic findings and influence on treatment decisions

    Urologic Oncology: Seminars and Original Investigations